PapersPMID:25374024
Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes.
- 01 · findings
- 4
- 02 · compound
- 1
- 03 · endpoints
- 4
- 04 · null
- 0
curcumin- Population, every finding
- adults with type 2 diabetes, reassessed from a prior 3-month curcuminoids RCT cohort
What moved
4 findingsHow to read these marks →curcumin — decreases C-reactive protein concentration
very limitedFindingreplicated ×5
“Curcuminoids supplementation led to significant decreases in serum A-FABP, C-reactive protein (CRP), tumor necrosis factor-α, and interleukin-6 levels.”
Quoted verbatim from Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes. - Study
- RCT
- Participants
- 100
- Duration
- 3 months
curcumin — decreases tumour necrosis factor alpha concentration
very limitedFindingreplicated ×6
“Curcuminoids supplementation led to significant decreases in serum A-FABP, C-reactive protein (CRP), tumor necrosis factor-α, and interleukin-6 levels.”
Quoted verbatim from Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes. - Study
- RCT
- Participants
- 100
- Duration
- 3 months
curcumin — increases superoxide dismutase activity
very limitedFindingreplicated ×2
“Curcuminoids supplementation also significantly increased serum superoxide dismutase (SOD) activity.”
Quoted verbatim from Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes. - Study
- RCT
- Participants
- 100
- Duration
- 3 months
curcumin — decreases interleukin-6 concentration
very limitedFindingreplicated ×8
“Curcuminoids supplementation led to significant decreases in serum A-FABP, C-reactive protein (CRP), tumor necrosis factor-α, and interleukin-6 levels.”
Quoted verbatim from Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type 2 Diabetes. - Study
- RCT
- Participants
- 100
- Duration
- 3 months
Study record
- Read under
- curcumin
- Design
- randomised controlled trial
- Species
- human
- Population
- adults with type 2 diabetes, reassessed from a prior 3-month curcuminoids RCT cohort
- Participants
- 100
- Comparator
- placebo
- Duration
- 90 days
- Endpoints measured
- 5
- Record
- extracted
- Readings recorded
- 2